127 related articles for article (PubMed ID: 25468201)
1. EGFR mutation testing in pulmonary adenocarcinoma: evaluation of tumor cell number and tumor percent in paraffin sections of 120 small biopsies.
Scarpino S; Pulcini F; Di Napoli A; Giubettini M; Ruco L
Lung Cancer; 2015 Jan; 87(1):8-13. PubMed ID: 25468201
[TBL] [Abstract][Full Text] [Related]
2. EGFR, KRAS, BRAF and HER2 testing in metastatic lung adenocarcinoma: Value of testing on samples with poor specimen adequacy and analysis of discrepancies.
Forest F; Stachowicz ML; Casteillo F; Karpathiou G; Gouzy-Grosjean F; Guilaubey C; Cottier M; Beal J; Clemenson A; Péoc'h M
Exp Mol Pathol; 2017 Dec; 103(3):306-310. PubMed ID: 29175303
[TBL] [Abstract][Full Text] [Related]
3. EGFR and KRAS molecular genotyping for pulmonary carcinomas: Feasibility of a simple and rapid technique implementable in any department of pathology.
Thomas De Montpréville V; Ghigna MR; Lacroix L; Lemoine A; Besse B; Mercier O; Fadel É; Dorfmuller P; Le Chevalier T;
Pathol Res Pract; 2017 Jul; 213(7):793-798. PubMed ID: 28554746
[TBL] [Abstract][Full Text] [Related]
4. Identification of EGFR Mutations by Immunohistochemistry with EGFR Mutation-Specific Antibodies in Biopsy and Resection Specimens from Pulmonary Adenocarcinoma.
Kim CH; Kim SH; Park SY; Yoo J; Kim SK; Kim HK
Cancer Res Treat; 2015 Oct; 47(4):653-60. PubMed ID: 25687872
[TBL] [Abstract][Full Text] [Related]
5. Can EGFR mutation status be reliably determined in pre-operative needle biopsies from adenocarcinomas of the lung?
Lindahl KH; Sørensen FB; Jonstrup SP; Olsen KE; Loeschke S
APMIS; 2015 Apr; 123(4):289-97. PubMed ID: 25556929
[TBL] [Abstract][Full Text] [Related]
6. Impact of tissue type and content of neoplastic cells of samples on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma.
Paliogiannis P; Attene F; Cossu A; Defraia E; Porcu G; Carta A; Sotgiu MI; Pazzola A; Cordero L; Capelli F; Fadda GM; Ortu S; Sotgiu G; Palomba G; Sini MC; Palmieri G; Colombino M
Mol Med Rep; 2015 Jul; 12(1):187-91. PubMed ID: 25683726
[TBL] [Abstract][Full Text] [Related]
7. Use of Exfoliative Specimens and Fine-Needle Aspiration Smears for Mutation Testing in Lung Adenocarcinoma.
Jain D; Ramachandrappa VS; Singh V; Malik PS; Madan K; Faruq M; Guleria R
Acta Cytol; 2017; 61(6):455-461. PubMed ID: 28848083
[TBL] [Abstract][Full Text] [Related]
8. Optimized algorithm for Sanger sequencing-based EGFR mutation analyses in NSCLC biopsies.
Warth A; Penzel R; Brandt R; Sers C; Fischer JR; Thomas M; Herth FJ; Dietel M; Schirmacher P; Bläker H
Virchows Arch; 2012 Apr; 460(4):407-14. PubMed ID: 22419261
[TBL] [Abstract][Full Text] [Related]
9. Novel use for an EGFR mutation-specific antibody in discriminating lung adenocarcinoma from reactive pneumocyte hyperplasia.
Mimori T; Kobayashi S; Tanaka A; Sasada S; Yoshida A; Izumo T; Sasaki N; Tsuchida T; Tsuta K
Histopathology; 2015 May; 66(6):816-23. PubMed ID: 25066097
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral distribution of EGFR-amplified and EGFR-mutated cells in pulmonary adenocarcinoma.
Soma S; Tsuta K; Takano T; Hatanaka Y; Yoshida A; Suzuki K; Asamura H; Tsuda H
Pathol Res Pract; 2014 Mar; 210(3):155-60. PubMed ID: 24355440
[TBL] [Abstract][Full Text] [Related]
11. Detection of an EGFR mutation in cytological specimens of lung adenocarcinoma.
Mohar B; Smojver Ježek S; Rajković Molek K; Štemberger C; Kurpis M; Kupanovac Ž; Samaržija M; Jonjić N; Grahovac B
Cytopathology; 2016 Dec; 27(6):444-451. PubMed ID: 26990359
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between EGFR Mutations and Pathological Classification and
Specimen of Lung Adenocarcinoma].
Kang L; Zheng J; Zhu X
Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):382-388. PubMed ID: 28641695
[TBL] [Abstract][Full Text] [Related]
13. Successful lung cancer EGFR sequencing from DNA extracted from TTF-1 immunohistochemistry slides: a new means to extend insufficient tissue.
Deftereos G; Sandoval A; Furtado LV; Bronner M; Matynia AP
Hum Pathol; 2020 Mar; 97():52-59. PubMed ID: 31978505
[TBL] [Abstract][Full Text] [Related]
14. MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics.
Kwon D; Koh J; Kim S; Go H; Kim YA; Keam B; Kim TM; Kim DW; Jeon YK; Chung DH
Lung Cancer; 2017 Apr; 106():131-137. PubMed ID: 28285687
[TBL] [Abstract][Full Text] [Related]
15. Comparison of EGFR mutation detection between the tissue and cytology using direct sequencing, pyrosequencing and peptide nucleic acid clamping in lung adenocarcinoma: Korean multicentre study.
Min KW; Kim WS; Jang SJ; Choi YD; Chang S; Jung SH; Kim L; Roh MS; Lee CS; Shim JW; Kim MJ; Lee GK;
QJM; 2016 Mar; 109(3):167-73. PubMed ID: 26031706
[TBL] [Abstract][Full Text] [Related]
16. Sensitive detection of EGFR mutations in cerebrospinal fluid from lung adenocarcinoma patients with brain metastases.
Yang H; Cai L; Zhang Y; Tan H; Deng Q; Zhao M; Xu X
J Mol Diagn; 2014 Sep; 16(5):558-563. PubMed ID: 24994671
[TBL] [Abstract][Full Text] [Related]
17. A novel, rapid point-of-care test for lung cancer patients to detect epidermal growth factor receptor gene mutations by using real-time droplet-PCR and fresh liquid cytology specimens.
Asaka S; Yoshizawa A; Matsuda K; Yamaguchi A; Yamamoto H; Shiina T; Nakata R; Ogawa K; Zhang M; Honda T
Oncol Rep; 2017 Feb; 37(2):1020-1026. PubMed ID: 27922678
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the Relationship Between the Quality of Small Biopsy Specimens of
Non-small Cell Lung Cancer and the Mutation Rate of EGFR Gene].
Li Y; Gu Y; Jiang J
Zhongguo Fei Ai Za Zhi; 2021 May; 24(5):331-337. PubMed ID: 34034456
[TBL] [Abstract][Full Text] [Related]
19. Cytology smears as diagnostic material for EGFR gene testing in non-small cell lung cancer.
Powrózek T; Krawczyk P; Pankowski J; Reszka K; Jakubiak M; Obrochta A; Wojas-Krawczyk K; Buczkowski J; Milanowski J
Tumori; 2015 Nov; 101(6):e151-3. PubMed ID: 26108238
[TBL] [Abstract][Full Text] [Related]
20. Immunostaining with EGFR mutation-specific antibodies: a reliable screening method for lung adenocarcinomas harboring EGFR mutation in biopsy and resection samples.
Fan X; Liu B; Xu H; Yu B; Shi S; Zhang J; Wang X; Wang J; Lu Z; Ma H; Zhou X
Hum Pathol; 2013 Aug; 44(8):1499-507. PubMed ID: 23465272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
